Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes
Cell Reports · 2024
DOI: 10.1016/j.celrep.2023.113668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Benjamin B Johnson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK. Hauptthemen laut MEDLINE: Heparan Sulfate Proteoglycans, Agrin. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Centre for the Replacement, Refinement and Reduction of Animals in Research, Wellcome Trust.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK.
- The Francis Crick Institute, London NW1 1AT, UK; NHLI, Imperial College London, London, UK.
- The Francis Crick Institute, London NW1 1AT, UK.
- The Francis Crick Institute, London NW1 1AT, UK; High-Throughput Screening Science Technology Platform, The Francis Crick Institute, London NW1 1AT, UK.
- School of Medicine, Regenerating and Modelling Tissues, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, UK.
- Institute of Life Course and Medical Sciences, William Henry Duncan Building, 6 West Derby Street, Liverpool L7 8TX, UK.
Förderung
- British Heart Foundation
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- Wellcome Trust
Zitieren
APA
Johnson, B. B., Cosson, M. V., Tsansizi, L. I., Holmes, T. L., Gilmore, T., Hampton, K., Song, O. R., Vo, N. T. N., Nasir, A., Chabronova, A., Denning, C., Peffers, M. J., Merry, C. L. R., Whitelock, J., Troeberg, L., Rushworth, S. A., Bernardo, A. S., & Smith, J. G. W. (2024). Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113668
Vancouver
Johnson BB, Cosson MV, Tsansizi LI, Holmes TL, Gilmore T, Hampton K, et al. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell Reports. 2024. doi:10.1016/j.celrep.2023.113668
BibTeX
@article{Johnson2024,
author = {Johnson, Benjamin B and Cosson, Marie-Victoire and Tsansizi, Lorenza I and Holmes, Terri L and Gilmore, Tegan and Hampton, Katherine and Song, Ok-Ryul and Vo, Nguyen T N and Nasir, Aishah and Chabronova, Alzbeta and Denning, Chris and Peffers, Mandy J and Merry, Catherine L R and Whitelock, John and Troeberg, Linda and Rushworth, Stuart A and Bernardo, Andreia S and Smith, James G W},
title = {Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2023.113668}
}
EUVIMED